AstraZeneca CEO Pascal Soriot goes one-on-one with Jim Cramer

Data centers aren't the only things that companies are spending billions of dollars to build the United States. But President Trump threatening steep tariffs on pharmaceutical imports that drug makers have announced a ton of manufacturing and R&D commitments in this country. Take Astroenica.That's the Anglo Swedish pharma giant. In July, Astroenica committed to spending $50 billion on US production R&D by 2030. And today, as part of that commitment, the company unveiled a $2 billion investment in Maryland t ...